| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.25B | +2.9% |
| Gross Profit | $1.05B | +2.5% |
| R&D Expense | $182.0M | -7.2% |
| SG&A Expense | $206.7M | -30.0% |
| Operating Income | $225.7M | +131.7% |
| Pre-tax Income | $194.3M | +520.8% |
| Income Tax | $70.1M | +3086.4% |
| Net Income | $124.2M | +326.8% |
| EPS (Basic) | $0.38 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $175.9M | +25.7% |
| Short-term Investments | $4.0M | — |
| Accounts Receivable | $225.6M | -8.3% |
| Current Assets | $454.0M | +0.7% |
| Total Assets | $6.44B | -0.4% |
| Current Liabilities | $632.9M | -2.9% |
| Long-term Debt | $1.32B | +7.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $465.4M | +26.0% |
| Investing Cash Flow | -$80.8M | -703.0% |
| Financing Cash Flow | -$347.9M | +49.6% |
| +375.0% |
| EPS (Diluted) | $0.38 | +375.0% |
| Total Liabilities |
| $4.93B |
| +3.3% |
| Stockholders' Equity | $1.51B | -10.9% |